These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement. Chauhan A; Apostolov R; van Langenberg D; Garg M Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016 [TBL] [Abstract][Full Text] [Related]
4. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile. Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913 [TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients. Bernard R; Hourigan SK; Nicholson MR J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S58-S63. PubMed ID: 34791396 [TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622 [TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Tan X; Johnson S Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233 [TBL] [Abstract][Full Text] [Related]
9. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363 [TBL] [Abstract][Full Text] [Related]
10. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic]. Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602 [TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence. Luo Y; Tixier EN; Grinspan AM Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714 [TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection. Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection. Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405 [TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation for recurrent Clostridioides difficile infection. Haber SL; Raney CRK; Larson TL; Lau JP Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890 [TBL] [Abstract][Full Text] [Related]
15. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection. Saha S; Mara K; Pardi DS; Khanna S Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567 [TBL] [Abstract][Full Text] [Related]
16. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis. Cappetto CM Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre. Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143 [TBL] [Abstract][Full Text] [Related]
19. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Tariq R; Hayat M; Pardi D; Khanna S Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1383-1392. PubMed ID: 33496893 [TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States. El Halabi J; Palmer N; Fox K; Kohane I; Farhat MR J Gastroenterol; 2022 Jan; 57(1):10-18. PubMed ID: 34495400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]